After the love fest, next awaits the real action. Hopefully does not take years.

#proqr

Well.. if Van Herk is sufficiently pissed, he can call an EGM to remove both of them.

This month will be interesting.

#ProQR

They changed delivery, so if the data gains by leaps and bounds, director term limits can take a backseat.

What I dont like is the Lily blackout even when there is progress payment of $1m in 1Q25.

Great to have him on retail side. And timing could'nt have been better to increase pressure before clinical ramps up.

Shareholders deserve to know whats going on.

$vtyx #sanofi #ventyx

Sanofi also made a similar equity investment into Ventyx at $3.8 per share last year.

NLRP3 inhibitor - VTX3232

#Sangamo

Press release - ".... will be sufficient to fund our planned operations into late in the third quarter of 2025."

Guess they bought 1 more quarter of life with latest shelf.

$VIR

Partner Brii Bio reported some impressive results 61% with an added vaccine. BRII-179.

This mess is drawing Europe closer to China. EVs and biotech for sure.

$18m too little cash still, they need at least $200m to realise the full value of their pipeline.

Or just sell out. Its now a 3-way matchup between Genentech, Astellas and Lily.

Great timing to get back in once again.

#SangamoTherapeutics